New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
June 17, 2014
08:32 EDTSQNMSequenom price target raised to $5 from $4 at Wedbush
Wedbush raised its price target on Sequenom after Quest agreed to begin using the company's MaterniT21 Plus test for fetal chromosomal abnormalities. The firm notes that the deal displaces one of Sequenom's competitors, and says that it will allow Sequenom to regain clear U.S. leadership of the category while improving its path to profitability. The firm keeps an Outperform rating on Sequnom.
News For SQNM From The Last 14 Days
Check below for free stories on SQNM the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
August 19, 2014
11:32 EDTSQNMLabCorp prenatal test a negative for Sequenom, says Maxim
Maxim views LabCorp's (LH) announcement today that it will begin offering the informaSeq prenatal test as a long-term negative for Sequenom (SQNM) due to increased competition. The news is also negative for Illumina (ILMN) and PerkinElmer (PKI), who both offer Non-Invasive Prenatal Tests, Maxim adds. The firm recommends buying shares of LabCorp and keeps a Buy rating on the name with a $130 price target.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use